Company Overview - Tongling Jeya Biotechnology Co., Ltd. was established in 1999 and specializes in the research, production, and sales of wet wipes, accumulating over 20 years of industry experience [2]. - The company was listed on the Shenzhen Stock Exchange's Growth Enterprise Market on December 3, 2021 [2]. Financial Performance - For the first three quarters of 2025, the company reported a revenue of 5.65 billion CNY and a net profit of 6,790.31 million CNY [2]. Q&A Highlights Production and Expansion - The U.S. factory is currently in the equipment installation and debugging phase, expected to commence production in the second half of this year [2]. - Land has been purchased in Egypt for future expansion to cover global markets outside the U.S., with the project still in the early planning stages [3]. Mergers and Acquisitions - The company is actively seeking quality acquisition targets that can create synergies with existing operations and add substantial value for long-term growth [3]. Product Lines and Market Strategy - There are no significant planned investments in the collagen business at this time [3]. - The performance of personal care products is currently limited in order volume, but customer expansion efforts are ongoing [3]. - The company's core competitive advantages lie in its long-term focus on the wet wipes market, with strengths in technology R&D, production processes, quality control, customer resources, and product variety [3]. Future Growth Prospects - Future growth is expected to come from deepening collaborations with existing international brand clients and expanding product categories and sales regions, as well as leveraging new market opportunities and localized supply chain advantages from the U.S. factory [3]. Compliance and Governance - The company adhered to the Shenzhen Stock Exchange's regulations during the investor communication event, ensuring no significant undisclosed information was leaked [3].

Market Overview - The personal care products sector increased by 0.64% on January 9, with Dengkang Oral leading the gains [1] - The Shanghai Composite Index closed at 4120.43, up 0.92%, while the Shenzhen Component Index closed at 14120.15, up 1.15% [1] Stock Performance - Key stocks in the personal care sector showed varied performance, with Dengkang Oral closing at 39.19, up 1.79% on a trading volume of 15,000 shares and a transaction value of 58.84 million yuan [1] - Other notable performers included: - Zhongshun Jierou at 8.38, up 1.09%, with a trading volume of 164,500 shares and a transaction value of 137 million yuan [1] - Wanjian Medical at 39.17, up 1.03%, with a transaction value of 166 million yuan [1] - Liangmian Needle at 5.88, up 1.03%, with a trading volume of 119,500 shares and a transaction value of 69.76 million yuan [1] Capital Flow - The personal care products sector experienced a net outflow of 9.1265 million yuan from institutional investors and 14.5833 million yuan from speculative funds, while retail investors saw a net inflow of 23.7098 million yuan [2] - Detailed capital flow for specific stocks included: - Runben Co. with a net inflow of 4.5229 million yuan from institutional investors, but a net outflow of 6.0816 million yuan from speculative funds [3] - Yiyi Co. had a net outflow of 51,000 yuan from institutional investors, but a net inflow of 619.27 million yuan from retail investors [3] - Dengkang Oral saw a net outflow of 1.5334 million yuan from institutional investors [3]

Market Overview - The personal care products sector increased by 0.52% on January 8, with Beijia leading the gains [1] - The Shanghai Composite Index closed at 4082.98, down 0.07%, while the Shenzhen Component Index closed at 13959.48, down 0.51% [1] Stock Performance - Beijia (603059) closed at 31.87, up 3.78% with a trading volume of 26,700 shares and a transaction value of 84.12 million yuan [1] - Reliable Co. (301009) closed at 12.93, up 1.41% with a trading volume of 29,000 shares [1] - HaoYue Care (600509) closed at 31.74, up 1.15% with a trading volume of 22,200 shares [1] - Other notable stocks include Jeya Co. (301108) at 34.39 (+0.88%), Liangmian Needle (600249) at 5.82 (+0.87%), and Runben Co. (603193) at 24.84 (+0.44%) [1] Capital Flow - The personal care products sector experienced a net outflow of 6.63 million yuan from institutional investors and 11.89 million yuan from speculative funds, while retail investors saw a net inflow of 18.52 million yuan [2] - The capital flow for individual stocks shows that Baia Co. (003006) had a net inflow of 5.69 million yuan from institutional investors, while it faced a net outflow of 12.99 million yuan from speculative funds [3] - Jeya Co. (301108) had a net outflow of 3.41 million yuan from institutional investors, but a net inflow of 2.17 million yuan from retail investors [3]

Core Viewpoint - The personal care products sector experienced a decline of 1.31% on January 7, with Yiyi Co., Ltd. leading the drop. The Shanghai Composite Index rose by 0.05% to close at 4085.77, while the Shenzhen Component Index increased by 0.06% to 14030.56 [1]. Market Performance - The closing prices and changes for key stocks in the personal care sector are as follows: - Beijiajie: 30.71, +0.46% - Jieya Co.: 34.09, +0.15% - Haoyue Care: 31.38, -0.03% - Runben Co.: 24.73, -0.36% - Dengkang Oral: 38.50, -0.88% - Kela Co.: 12.75, -1.01% - Wanjian Medical: 38.60, -1.08% - Liangmian Needle: 5.77, -2.04% - Baiya Co.: 21.13, -2.22% - Zhongshun Jiesang: 8.31, -2.46% [1][2]. Capital Flow - On that day, the personal care products sector saw a net outflow of 755.65 million yuan from institutional investors, while retail investors experienced a net outflow of 2027.61 million yuan. Conversely, speculative funds had a net inflow of 2783.26 million yuan [2][3]. Individual Stock Capital Flow - The capital flow for individual stocks in the personal care sector is as follows: - Zhongshun Jiesang: Net inflow of 804.63 million yuan from institutional investors, with a net outflow of 1643.93 million yuan from retail investors [3]. - Wanjian Medical: Net inflow of 610.21 million yuan from institutional investors, with a slight net outflow from retail investors [3]. - Haoyue Care: Net inflow of 338.41 million yuan from institutional investors, but a significant net outflow from retail investors [3]. - Baiya Co.: Net inflow of 240.08 million yuan from institutional investors, with a net outflow from retail investors [3].

证券日报网讯1月6日，洁雅股份（301108）在互动平台回答投资者提问时表示，截至2025年12月31日公 司股东户数为7144户。 ...

证券代码：301108 证券简称：洁雅股份 公告编号：2025-092 铜陵洁雅生物科技股份有限公司 关于对外担保的进展公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 一、担保情况概述 铜陵洁雅生物科技股份有限公司（以下简称"公司"或"洁雅股份"）于 2025 年 12 月 24 日召开第六届董事会第六次会议，审议通过了《关于公司及全 资孙公司向银行申请综合授信额度并为全资孙公司提供担保的议案》，同意公司 为全资孙公司 GLOBALWIPES PTE. LTD.（以下简称"新加坡全资孙公司"）向 兴业银行股份有限公司合肥分行（以下简称"兴业银行"）申请额度不超过人民 币 15,000 万元（含等值外币）的综合授信额度提供同等额度的质押担保，有效 期三年。 具 体 内 容 详 见 公 司 2025 年 12 月 24 日 在 巨 潮 资 讯 网 （http://www.cninfo.com.cn）披露的《关于公司及全资孙公司向银行申请综合授 信额度并为全资孙公司提供担保的公告》（公告编号：2025-088）。 二、担保进展情况 公司与兴业银行签订了《保证金 ...

Market Overview - The personal care products sector increased by 0.23% on December 31, with Yanjiang Co., Ltd. leading the gains [1] - The Shanghai Composite Index closed at 3968.84, up 0.09%, while the Shenzhen Component Index closed at 13525.02, down 0.58% [1] Stock Performance - Yanjiang Co., Ltd. (300658) closed at 14.82, up 11.68% with a trading volume of 314,600 shares and a transaction value of 445 million yuan [1] - Other notable stocks include: - Dengkang Oral (001328) at 39.48, up 1.23% [1] - Zhongshun Jierou (002511) at 8.56, up 1.06% [1] - Beijia Clean (603059) at 30.08, up 0.37% [1] - Reliable Co., Ltd. (301009) at 12.68, up 0.32% [1] - Runben Co., Ltd. (603193) at 24.23, up 0.12% [1] - Haoyue Nursing (605009) at 30.90, up 0.03% [1] - Ziya Co., Ltd. (003006) at 21.84, down 0.46% [1] - Wanjian Medical (300888) at 37.84, down 0.58% [1] - Liangmian Needle (600249) at 5.75, down 1.71% [1] Capital Flow - The personal care products sector experienced a net outflow of 31.67 million yuan from institutional investors, while retail investors saw a net inflow of 26.33 million yuan [2] - The capital flow for individual stocks shows: - Yanjiang Co., Ltd. had a net inflow of 18.80 million yuan from institutional investors [3] - Dengkang Oral had a net inflow of 0.90 million yuan from retail investors [3] - Reliable Co., Ltd. had a net outflow of 3.37 million yuan from institutional investors [3] - Zhongshun Jierou had a net outflow of 7.21 million yuan from institutional investors [3] - Yiyi Co., Ltd. had a net outflow of 9.23 million yuan from institutional investors [3]

Market Overview - The personal care products sector experienced a slight decline of 0.1% on December 30, with Liangmian Needle leading the drop [1] - The Shanghai Composite Index closed at 3965.12, down 0.0%, while the Shenzhen Component Index closed at 13604.07, up 0.49% [1] Stock Performance - Notable stock performances in the personal care sector included: - Zhiya Co., Ltd. (003006) rose by 3.69% to close at 21.94, with a trading volume of 80,900 shares and a turnover of 178 million yuan [1] - Jieya Co., Ltd. (301108) increased by 1.04% to 33.86, with a trading volume of 10,700 shares and a turnover of 36.07 million yuan [1] - Liangmian Needle (600249) fell by 1.52% to 5.85, with a trading volume of 99,500 shares and a turnover of 58.49 million yuan [2] Capital Flow - The personal care products sector saw a net inflow of 23.84 million yuan from institutional investors, while retail investors experienced a net outflow of 48.31 million yuan [2] - The capital flow for individual stocks showed: - Yanjiang Co., Ltd. (300658) had a net inflow of 33.52 million yuan from institutional investors [3] - Liangmian Needle (600249) had a net outflow of 3.21 million yuan from institutional investors [3] Summary of Individual Stocks - The following stocks had significant capital movements: - Zhiya Co., Ltd. (003006) had a net inflow of 17.45 million yuan from institutional investors [3] - Jieya Co., Ltd. (301108) saw a net outflow of 0.87 million yuan from institutional investors [3] - Stable Medical (300888) had a net outflow of 3.61 million yuan from institutional investors [3]

证券代码：301108 证券简称：洁雅股份 公告编号：2025-091 铜陵洁雅生物科技股份有限公司 关于对外投资的进展公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 一、对外投资概述 为满足业务发展需要，深化与海外客户的合作关系，推进国际业务发展布局， 铜陵洁雅生物科技股份有限公司（以下简称"公司"）全资子公司洁雅生物科技 （厦门）有限责任公司（以下简称"洁雅厦门"）以自有资金 35 万美元在新加 坡设立全资公司，主要从事贸易批发业务。 具 体 内 容 详 见 公 司 2025 年 11 月 28 日 在 巨 潮 资 讯 网 （http://www.cninfo.com.cn）披露的《关于全资子公司对外投资设立新加坡子公 司并完成工商注册登记的公告》（公告编号：2025-086）。 铜陵洁雅生物科技股份有限公司董事会 二、对外投资进展情况 截至本公告披露日，公司全资子公司洁雅厦门在新加坡投资设立全资公司的 进展情况如下： 1. 公司已取得中国（福建）自由贸易试验区厦门片区管理委员会印发的《境 外投资项目备案通知书》（厦自贸象备〔2025〕第 30 号） ...

Market Overview - The personal care products sector increased by 0.49% compared to the previous trading day, with Dengkang Oral leading the gains [1] - The Shanghai Composite Index closed at 3965.28, up 0.04%, while the Shenzhen Component Index closed at 13537.1, down 0.49% [1] Stock Performance - Dengkang Oral (001328) closed at 38.95, up 2.04% with a trading volume of 19,000 shares and a transaction value of 73.72 million yuan [1] - Other notable performers include: - Yanjing Co. (300658) at 13.18, up 1.62% [1] - Stable Medical (300888) at 38.64, up 1.47% with a transaction value of 252 million yuan [1] - Zhongshun Jiesang (002511) at 8.45, up 1.32% with a transaction value of 191 million yuan [1] Capital Flow - The personal care products sector experienced a net outflow of 9.12 million yuan from institutional investors and 8.75 million yuan from retail investors, while retail investors saw a net inflow of 17.87 million yuan [2] - The capital flow for individual stocks shows: - Stable Medical had a net inflow of 18.89 million yuan from institutional investors [3] - Dengkang Oral saw a net outflow of 3.00 million yuan from institutional investors [3] - Yanjing Co. had a net inflow of 1.24 million yuan from institutional investors [3] Summary of Individual Stocks - The following stocks had significant capital movements: - Dengkang Oral: Institutional net outflow of 3.00 million yuan, retail net inflow of 0.80 million yuan [3] - Stable Medical: Institutional net inflow of 18.89 million yuan, retail net outflow of 20.84 million yuan [3] - Zhongshun Jiesang: Institutional net outflow of 3.24 million yuan, retail net inflow of 4.70 million yuan [3]